Growth Factors for Cell Culture: Buying Guide

Growth factors are recombinant proteins added to cell culture media to signal proliferation, survival, or differentiation — EGF, FGF2 (bFGF), PDGF, IGF-1, TGF-β1, and VEGF are the ones a lab is most likely to purchase, alongside insulin and transferrin, which function as growth-factor-like supplements in serum-free formulations. For a lab manager or procurement officer, the sourcing decision is rarely just “which catalog number” — it involves choosing between animal-derived and recombinant sources, evaluating purity and bioactivity specifications, and, for regulated or GMP workflows, confirming a supplier can support ancillary-material documentation requirements.

This guide covers what to evaluate when sourcing growth factors for cell culture: the common types and their typical applications, the recombinant-vs-animal-derived and carrier-free-vs-carrier-protein decisions, how to read a certificate of analysis (CoA), and what changes when the growth factor is going into a GMP-grade cell or gene therapy manufacturing process rather than a research application.

What Counts as a Growth Factor in This Context

In a cell culture supply context, “growth factor” usually refers to a purified or recombinant polypeptide added to basal media (or to a defined/serum-free formulation) to replace a specific function that serum otherwise provides in an undefined way. This is distinct from the culture medium itself and from bulk protein supplements like bovine serum albumin (BSA), though BSA is often used as a carrier protein for growth factors (see below). Common categories:

Mitogens — drive proliferation (e.g., EGF, FGF2, PDGF).
Survival/anti-apoptotic factors — support viability under stress or low-density conditions (e.g., IGF-1).
Differentiation factors — direct lineage commitment in stem/progenitor cell protocols (e.g., TGF-β family members, BMPs, activin A).
Angiogenic/vascular factors — used in endothelial and vascular biology work (e.g., VEGF).

Insulin and transferrin are technically not growth factors in the strict signaling sense, but they are procured, specified, and quality-controlled the same way, and are commonly bundled into “growth factor and supplement” catalog categories — worth noting when comparing vendor product lines.

Recombinant vs. Animal- or Tissue-Derived Sourcing

Most growth factors sold today are recombinant, expressed in a host system (E. coli, yeast, insect cells, or mammalian cells such as HEK293 or CHO) rather than purified from animal tissue. This matters for procurement in three ways:

Lot-to-lot consistency. Recombinant production in a defined expression system is generally more reproducible than tissue extraction, which is one reason serum-free and xeno-free protocols favor recombinant growth factors over undefined animal-derived supplements — see CASRAI’s xeno-free media and chemically defined media entries for how this fits into the broader media-formulation decision.
Host system affects post-translational modification and cost. A growth factor expressed in E. coli is typically non-glycosylated and cheaper; the same factor expressed in a mammalian system may carry glycosylation closer to the native human protein, which can matter for some differentiation protocols and is usually reflected in a significant price difference. Check the technical data sheet for expression host, not just species (e.g., “human EGF” tells you the sequence; it doesn’t tell you the host).
Regulatory and supply-chain traceability. Animal-derived components carry TSE/BSE sourcing documentation requirements; recombinant, animal-component-free (ACF) growth factors avoid that documentation burden and are the default choice for cell and gene therapy manufacturing, xenotransplantation-adjacent work, and any protocol intended to scale toward clinical use.

Carrier-Free vs. Carrier-Protein Formulations

Lyophilized growth factors are frequently formulated with a carrier protein — usually BSA or human serum albumin (HSA) — to stabilize the protein during freeze-drying and prevent adsorption to vial surfaces at the very low concentrations growth factors are used at (often nanogram-to-microgram per mL of media). Carrier-free (also marketed as “carrier-free/CF” or “animal-free carrier-free”) formulations exist for applications where even trace carrier protein is a confound or a regulatory concern — immunoassay development, mass-spec-based work, or GMP manufacturing where every input protein needs to be accounted for in the ancillary-material file. Carrier-free growth factors typically cost more, can be less stable in dilute working solutions, and require more careful handling (e.g., adding a small amount of a compatible carrier at the point of use, per the supplier’s technical bulletin) — factor this into total cost of ownership, not just the per-vial price.

Reading the Certificate of Analysis: What to Actually Check

A growth-factor CoA should let you verify the product independently of marketing claims. The fields worth checking before you approve a vendor or a lot substitution:

Purity — typically reported by SDS-PAGE and/or HPLC, usually ≥95–98% for research-grade recombinant growth factors.
Bioactivity (ED₅₀) — the concentration producing 50% of maximal response in a defined cell-based bioassay (e.g., a proliferation assay in a responsive cell line). This is the specification that actually predicts performance in your culture — purity alone does not guarantee activity, since misfolded or degraded protein can still run correctly on a gel.
Endotoxin level — reported in EU/μg, typically specified as below a stated ceiling (commonly ≤1.0 EU/μg for research grade; tighter limits are specified for sensitive applications such as immune cell culture or clinical-grade manufacturing).
Sequence/species and expression host — confirms the product matches your protocol’s specified factor (human vs. murine EGF, for example, are not interchangeable in many published protocols).
Formulation — carrier protein (yes/no, which one), buffer, and recommended reconstitution solvent/concentration.
Stability data — recommended storage temperature, shelf life as lyophilized powder, and stability window once reconstituted (typically short at working concentrations without a carrier protein or without aliquoting).

For a lot change or a new vendor, the practical procurement step is a small-scale functional qualification — run your existing protocol side-by-side with the incumbent lot/vendor and compare growth curves or the relevant functional readout before switching the whole culture over, rather than relying on the CoA numbers alone. Media and supplement changes are a well-documented source of unexplained culture drift, and growth factors are one of the more potent single ingredients when it comes to that risk.

Research Grade vs. GMP/Ancillary-Material Grade

Growth factors used in a research lab and growth factors used to manufacture a cell or gene therapy product are subject to different sourcing expectations, even when the protein sequence is identical:

Research-grade growth factors are qualified for reproducibility and bioactivity but are not manufactured or documented under a pharmaceutical quality system, and typically carry a “not for human use” or “research use only” (RUO) label.
GMP-grade / ancillary-material-grade growth factors are manufactured under a quality system (frequently ISO 13485 or a GMP-aligned system), with full traceability of raw materials, batch records, and a regulatory support file the manufacturer can provide to a therapy developer’s regulatory team. In FDA and international guidance, reagents like growth factors that contact a cell or gene therapy product during manufacturing but are not part of the final product are referred to as ancillary materials, and their qualification (grade, testing, removal/clearance where relevant) is an explicit part of the manufacturing process’s regulatory file.

If you are procuring for anything upstream of a clinical-grade or IND-enabling process, confirm with the supplier, in writing, which grade you are buying and whether a Drug Master File (DMF) or equivalent regulatory support package exists for that specific catalog number — grade is not always obvious from the product name alone, and “premium” or “cell culture grade” branding on a listing is not the same claim as GMP/ancillary-material grade.

Storage, Handling, and Stability

Lyophilized (powder) format is generally more stable for long-term storage (commonly quoted at -20°C for a year or more unopened) and is the better choice for infrequent use or long-term inventory.
Liquid/pre-diluted format is more convenient for frequent use but has a shorter shelf life and is more sensitive to freeze-thaw cycling.
Reconstitute into single-use aliquots at receipt rather than repeatedly freeze-thawing a stock vial — growth factor activity loss from freeze-thaw cycling is one of the more common, and most avoidable, causes of unexplained culture performance drift traced back to a reagent rather than the cells.
Cold-chain shipping — most growth factors ship on dry ice or with cold packs; confirm the vendor’s shipping conditions match your site’s receiving capability, and build a receiving-inspection step (temperature indicator check, prompt storage) into your procurement SOP the same way you would for serum or other temperature-sensitive biologics.

Vendor Evaluation Checklist for Procurement

When comparing suppliers or qualifying a new one, the criteria that hold up to scrutiny are documented and testable, not marketing claims:

Does the CoA report purity and bioactivity (ED₅₀ or equivalent functional assay), not purity alone?
Is the expression host and species disclosed, not just “human” or “recombinant”?
Is a carrier-free option available if your application needs one, and is the difference clearly labeled?
For regulated work: can the supplier provide ancillary-material-grade product with a regulatory support file, and is that a genuinely separate SKU from the research-grade product (not the same catalog number with a different label)?
What is the lot-to-lot change notification policy, and will the vendor supply a retain sample or advance notice before discontinuing or reformulating a product you depend on?
What is quoted lead time and minimum order quantity, and does that match your consumption rate without forcing large single-lot purchases that then age past their stability window?

Distributors and specialty biologics suppliers — for example LAC Health, which distributes cell culture reagents including growth factors and serum-replacement products alongside sourcing and documentation support — are one channel through which labs source these materials, particularly when consolidating vendor qualification across FBS, growth factors, and other media components with a single supplier relationship; the evaluation criteria above apply regardless of which distributor or manufacturer you are qualifying.

Frequently Asked Questions

What is the difference between a growth factor and a cytokine?

The terms overlap heavily and are often used interchangeably in product catalogs. Historically, “growth factor” emphasized proliferation/differentiation signaling in a broad range of cell types (EGF, FGF, PDGF), while “cytokine” emphasized immune-cell signaling (interleukins, interferons). In practice, both are small signaling proteins acting through cell-surface receptors, and many vendors group them under a single “growth factors and cytokines” product category.

Do I need growth factors if I use fetal bovine serum (FBS)?

Serum already contains an undefined mixture of growth factors, which is part of why it supports robust growth without further supplementation for many standard cell lines. Purified growth factors become necessary when moving to serum-free or chemically defined media (where the undefined serum components have been removed and must be replaced individually), or when a specific protocol calls for a defined factor at a controlled concentration that serum cannot reliably provide lot-to-lot. See CASRAI’s guides on the fetal bovine serum supply chain and on human platelet lysate as a serum alternative for how this decision fits into a broader media strategy.

How should I store growth factors between uses?

Reconstitute lyophilized product into single-use aliquots at the concentration and buffer the supplier recommends, store at the vendor-specified temperature (commonly -20°C or colder for long-term storage), and avoid repeated freeze-thaw of a working stock — see the storage and handling section above.

What does “carrier-free” mean and do I need it?

Carrier-free growth factors are formulated without a stabilizing carrier protein (typically BSA or HSA). Most standard research culture work does not require carrier-free product and benefits from the stability the carrier provides; carrier-free is worth the added cost and handling care specifically when trace carrier protein would interfere with a downstream assay or when you are building a fully defined, ancillary-material-documented process for regulated manufacturing.

Is a higher price always a sign of higher quality for growth factors?

Not reliably. Price differences track expression host (mammalian vs. bacterial), formulation (carrier-free vs. carrier-protein), grade (GMP/ancillary-material vs. research), and fill size at least as much as they track quality. The CoA fields described above — purity, bioactivity, endotoxin, and disclosed expression host — are the actual comparison points; use them rather than price or brand recognition alone when qualifying a new vendor or a lower-cost alternative to an incumbent product.

Growth Factors for Cell Culture: A Procurement and Sourcing Guide

Ask about Growth Factors for Cell Culture: A Procurement and Sourcing Guide